140 related articles for article (PubMed ID: 32069470)
1. Association of Disease Subtype and Duration with Echocardiographic Evidence of Pulmonary Hypertension in Myeloproliferative Neoplasm.
Yaylali YT; Yilmaz S; Akgun-Cagliyan G; Kilic O; Kaya E; Senol H; Ozen F
Med Princ Pract; 2020; 29(5):486-491. PubMed ID: 32069470
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk factors of high echocardiographic probability of pulmonary hypertension in myeloproliferative neoplasms patients.
Jindamai Y; Rattarittamrong E; Phrommintikul A; Yongsmith L; Piriyakhuntorn P; Rattanathammethee T; Hantrakool S; Chai-Adisaksopha C; Tantiworawit A; Norasetthada L
Int J Hematol; 2020 Nov; 112(5):631-639. PubMed ID: 32700192
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk factors for Pulmonary Hypertension associated with chronic Myeloproliferative Neoplasms.
Ferrari A; Scandura J; Masciulli A; Krichevsky S; Gavazzi A; Barbui T
Eur J Haematol; 2021 Feb; 106(2):250-259. PubMed ID: 33135220
[TBL] [Abstract][Full Text] [Related]
4. Echocardiographic predictors of adverse short-term outcomes after heart surgery in patients with mitral regurgitation and pulmonary hypertension.
Corciova FC; Corciova C; Georgescu CA; Enache M; Anghel D; Bartos O; Tinica G
Heart Surg Forum; 2012 Jun; 15(3):E127-32. PubMed ID: 22698598
[TBL] [Abstract][Full Text] [Related]
5. Frequency and etiology of pulmonary hypertension in patients with myeloproliferative neoplasms.
Brabrand M; Hansen KN; Laursen CB; Larsen TS; Vestergaard H; Abildgaard N
Eur J Haematol; 2019 Mar; 102(3):227-234. PubMed ID: 30450659
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of pulmonary hypertension in myelofibrosis.
Lopez-Mattei J; Verstovsek S; Fellman B; Iliescu C; Bhatti K; Hassan SA; Kim P; Gray BA; Palaskas NL; Grosu HB; Mamas MA; Faiz SA
Ann Hematol; 2020 Apr; 99(4):781-789. PubMed ID: 32076825
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary hypertension in patients with myeloproliferative neoplasms: A large cohort of 183 patients.
Venton G; Turcanu M; Colle J; Thuny F; Chebrek S; Farnault L; Mercier C; Ivanov V; Fanciullino R; Suchon P; Jarrot PA; Aissi K; Roche P; Cautela J; Arcani R; Costello R
Eur J Intern Med; 2019 Oct; 68():71-75. PubMed ID: 31421946
[TBL] [Abstract][Full Text] [Related]
8. Risk of echocardiographic pulmonary hypertension in individuals with human immunodeficiency virus-hepatitis C virus coinfection.
Sangal RB; Taylor LE; Gillani F; Poppas A; Klinger JR; Ventetuolo CE
Ann Am Thorac Soc; 2014 Dec; 11(10):1553-9. PubMed ID: 25375659
[TBL] [Abstract][Full Text] [Related]
9. MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and Algeria.
Yassin MA; Taher A; Mathews V; Hou HA; Shamsi T; Tuğlular TF; Xiao Z; Kim SJ; Depei W; Li J; Rippin G; Sadek I; Siddiqui A; Wong RS
Cancer Med; 2020 Jul; 9(13):4512-4526. PubMed ID: 32351024
[TBL] [Abstract][Full Text] [Related]
10. Clinical Manifestations and Risk Factors for Complications of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
Duangnapasatit B; Rattarittamrong E; Rattanathammethee T; Hantrakool S; Chai-Adisaksopha C; Tantiworawit A; Norasetthada L
Asian Pac J Cancer Prev; 2015; 16(12):5013-8. PubMed ID: 26163633
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and Effect on Survival of Pulmonary Hypertension in Myelofibrosis.
Austin M; Quesenberry PJ; Ventetuolo CE; Liang O; Reagan JL
Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):593-597. PubMed ID: 31262666
[TBL] [Abstract][Full Text] [Related]
12. Estimation of pulmonary pressures and diagnosis of pulmonary hypertension by Doppler echocardiography: a retrospective comparison of routine echocardiography and invasive hemodynamics.
Lafitte S; Pillois X; Reant P; Picard F; Arsac F; Dijos M; Coste P; Dos Santos P; Roudaut R
J Am Soc Echocardiogr; 2013 May; 26(5):457-63. PubMed ID: 23510536
[TBL] [Abstract][Full Text] [Related]
13. Incremental Utility of Right Ventricular Dysfunction in Patients With Myeloproliferative Neoplasm-Associated Pulmonary Hypertension.
Kim J; Krichevsky S; Xie L; Palumbo MC; Rodriguez-Diego S; Yum B; Brouwer L; Silver RT; Schafer AI; Ritchie EK; Yabut MM; Sosner C; Horn EM; Devereux RB; Scandura JM; Weinsaft JW
J Am Soc Echocardiogr; 2019 Dec; 32(12):1574-1585. PubMed ID: 31587969
[TBL] [Abstract][Full Text] [Related]
14. Analysis of clinical characteristics of bone marrow proliferative tumor progression to acute myeloid leukemia.
Li Y; Zhang XY; Han J; Wang L
Cancer Biomark; 2018; 23(4):469-472. PubMed ID: 30452397
[TBL] [Abstract][Full Text] [Related]
15. Correlation between JAK2 allele burden and pulmonary arterial hypertension and hematological parameters in Philadelphia negative JAK2 positive myeloproliferative neoplasms. An Egyptian experience.
Mattar MM; Morad MA; El Husseiny NM; Ali NH; El Demerdash DM
Ann Hematol; 2016 Oct; 95(10):1611-6. PubMed ID: 27468853
[TBL] [Abstract][Full Text] [Related]
16. Echocardiographic evolution of pulmonary artery pressure after acute pulmonary embolism. Results from IPER registry.
Casazza F; Bongarzoni A; Forgione C; Cuccia C; Imperadore F; Arrigo G; Floriani I; Pignataro L
Thromb Res; 2014 Dec; 134(6):1224-8. PubMed ID: 25288469
[TBL] [Abstract][Full Text] [Related]
17. Thrombosis in the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
Sankar K; Stein BL; Rampal RK
Cancer Treat Res; 2019; 179():159-178. PubMed ID: 31317487
[TBL] [Abstract][Full Text] [Related]
18. Echocardiographic and clinical characteristics of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis.
Chaowalit N; Pellikka PA; Decker PA; Aubry MC; Krowka MJ; Ryu JH; Vassallo R
Mayo Clin Proc; 2004 Oct; 79(10):1269-75. PubMed ID: 15473409
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of Echocardiography to Evaluate Pulmonary Vascular and RV Function During Exercise.
Claessen G; La Gerche A; Voigt JU; Dymarkowski S; Schnell F; Petit T; Willems R; Claus P; Delcroix M; Heidbuchel H
JACC Cardiovasc Imaging; 2016 May; 9(5):532-43. PubMed ID: 26508387
[TBL] [Abstract][Full Text] [Related]
20. Incidence of myeloproliferative neoplasms - trends by subgroup and age in a population-based study in Sweden.
Hultcrantz M; Ravn Landtblom A; Andréasson B; Samuelsson J; Dickman PW; Kristinsson SY; Björkholm M; Andersson TM
J Intern Med; 2020 Apr; 287(4):448-454. PubMed ID: 31927786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
